---
title: Slide 3
image: accionesempresas_ENG.png
---

# Companies profit with the pandemic

Companies have increased their profits with the development of COVID-19 vaccines. The stock of companies that have WHO-approved vaccines and are listed on the stock exchange have risen in value between January 2020 and May 2022. They have also increased their earnings and sales and the compensation of the persons who manage these companies has increased exponentially. **[Astra Zeneca](https://www.sec.gov/ix?doc=/Archives/edgar/data/0000901832/000110465922025720/azn-20211231x20f.htm){:target="_blank"}** reports that, in 2021, product sales grew 41% to 36.541 billion dollars, including revenues from its COVID-19 vaccine. **Pascal Soriot** y **Aradhana Sarin**, CEO and CFO of AstraZeneca, in addition to their generous salaries, [received additional bonuses](https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2021/pdf/AstraZeneca_AR_2021.pdf){:target="_blank"} equal to [237.5%](https://www.sec.gov/Archives/edgar/data/901832/000095010317002275/dp73779_ex0403.htm){:target="_blank"} and [168% of their base salary](https://www.sec.gov/Archives/edgar/data/0000901832/000110465922025720/azn-20211231xex4d2.htm) respectively. In 2021, for the first time, **[Moderna, Inc.](https://www.sec.gov/ix?doc=/Archives/edgar/data/1682852/000168285222000012/mrna-20211231.htm){:target="_blank"}** reported a positive net revenue, due to sales of 824 million vaccine doses, of 12.202 billion dollars, 1733% more than in 2020. In 2021, **[Stephane Bancel](https://www.forbes.com/profile/stephane-bancel/?list=rtb/&sh=7308a27e3742){:target="_blank"}**, CEO and holder of 4% of Moderna’s shares, joined the exclusive list of the world’s richest persons with equity of 4.9 billion dollars.
